What is the clinical evidence from this study?

Study design: Case Report. Population: Danon disease (LAMP-2 deficiency) (n=8). Intervention: Heart transplantation. Primary outcome: Survival and clinical outcome.

What question did this study set out to answer?

To report a novel Lamp-2 gene mutation and the outcomes of heart transplantation in Danon disease.

December 21, 2005Muscle & Nerve

Novel Lamp‐2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease

View Full Paper

Ask AI

Bookmark

Key result

Heart transplantation successfully treated one patient with Danon disease, a frequently fatal condition, with more than 5 years of follow-up.

Why the study?

Can heart transplantation successfully treat lethal cardiomyopathy in patients with Danon disease?

Key Points

To report a novel Lamp-2 gene mutation and the outcomes of heart transplantation in Danon disease.
Descriptive case report of a Sardinian family with eight affected individuals and genetic analysis.
Documented characteristics include the mutation identified in exon 2 (c.102_103delAG).
Follow-up duration exceeded 5 years for the heart transplantation case.
Isolated cardiomyopathy developed in adulthood for females; males had earlier onset with multiple complications.
Three females and three males died from cardiomyopathy, highlighting the disease's severity.
Successful heart transplantation indicated as a potential treatment option.

Study Design

Type

Case Report (n=8)

Multicenter

Structured PICO

Can heart transplantation successfully treat lethal cardiomyopathy in patients with Danon disease?

Population

8 patients (4 females, 4 males) from a single Sardinian family with Danon disease and a novel Lamp-2 gene mutation, including one treated with heart transplantation.

Intervention

Heart transplantation

Outcome

Survival and successful treatment of cardiomyopathyhard clinical

Danon disease is a frequently fatal genetic condition causing lethal cardiomyopathy that can be successfully treated with heart transplantation.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Supports transplantation feasibility in Danon cardiomyopathy; leaves open need for larger studies to guide practice.

Cite This Study

Echaniz‐Laguna et al. (2005) conducted a case report in Danon disease (LAMP-2 deficiency) (n=8). Heart transplantation was evaluated on Survival and clinical outcome. Heart transplantation successfully treated one patient with Danon disease, a frequently fatal condition, with more than 5 years of follow-up.

synapsesocial.com/papers/6a207a45389e15e238f48df4 https://doi.org/10.1002/mus.20471

Topics

Heart transplantation Cardiac device therapy

View Full Paper

Ask AI

Bookmark

Novel Lamp‐2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease

Key Points

Study Design

Structured PICO

Discussion

Implication

Cite This Study

Topics

Novel Lamp‐2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease

Key Points

Study Design

Structured PICO

Discussion

Implication

Cite This Study

Keep reading

Topics

Keep reading